{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:31:03Z","timestamp":1786325463139,"version":"build-2736575974"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Trade, Industry & Energy","award":["RS-2023-00230655"],"award-info":[{"award-number":["RS-2023-00230655"]}]},{"name":"Ministry of Trade, Industry & Energy","award":["RS-2024-00439266"],"award-info":[{"award-number":["RS-2024-00439266"]}]},{"name":"Ministry of Trade, Industry & Energy","award":["RS-2024-00438174"],"award-info":[{"award-number":["RS-2024-00438174"]}]},{"award":["RS-2023-00230655"],"award-info":[{"award-number":["RS-2023-00230655"]}],"id":[{"id":"https:\/\/ror.org\/008nkqk13","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RS-2024-00439266"],"award-info":[{"award-number":["RS-2024-00439266"]}],"id":[{"id":"https:\/\/ror.org\/008nkqk13","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RS-2024-00438174"],"award-info":[{"award-number":["RS-2024-00438174"]}],"id":[{"id":"https:\/\/ror.org\/008nkqk13","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: In this study, a novel reversed-phase high-performance liquid chromatography (RP-HPLC) method was established for the quality control of amiodarone hydrochloride, overcoming the limitations of the legacy compendial protocol. The conventional United States Pharmacopeia method requires a 10-fold sample dilution to avoid column overload and matrix interference from polysorbate 80. Attempting direct injection under conventional conditions severely compromises data reliability, leading to severe band broadening and peak distortion. Methods: To fairly evaluate the intrinsic separation capacity of the analytical systems, preliminary experiments were conducted using identical, undiluted dissolution samples. Through precise chromatographic redesign, the novel method eliminates the pre-treatment dilution step. Furthermore, the reliability, precision, and robustness of the proposed method were comprehensively validated in strict accordance with the International Council for Harmonisation Q2 guidelines. Results: Even upon direct injection of highly concentrated samples, the optimized system focuses broad peaks into sharp, symmetric, and narrow bands, increasing analytical sensitivity and theoretical plates. Furthermore, it maximizes intra-column separation efficiency, achieving complete baseline isolation of amiodarone from surfactant interferences within a retention time of approximately 6.6 min, thereby significantly improving analytical throughput. Conclusions: By eliminating cumbersome sample preparation, minimizing analysis time, and enhancing quantitative integrity, this validated RP-HPLC method offers an efficient, high-throughput standard analytical platform. It is highly suitable for rapid routine quality control and high-precision dissolution testing of generic amiodarone pharmaceuticals in industrial settings.<\/jats:p>","DOI":"10.3390\/ph19081255","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:20:03Z","timestamp":1786324803000},"page":"1255","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AQbD-Driven RP-HPLC Method for Rapid Dissolution Monitoring of Amiodarone Hydrochloride Tablets Without Sample Dilution"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8555-4667","authenticated-orcid":false,"given":"Ju-Hyun","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7744-8573","authenticated-orcid":false,"given":"Joo-Eun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea"},{"name":"Biopharmaceutical Chemistry Major, School of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea"},{"name":"Department of Pharmaceutical Engineering, Kookmin University, Seoul 02707, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.11591\/ijict.v6i1.pp31-36","article-title":"Detection & Classification of Cardiac Arrhythmia","volume":"6","author":"Jadhav","year":"2017","journal-title":"Int. J. Inform. Commun. Technol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5530\/jcdr.2015.1.2","article-title":"Prophylactic effect of amiodarone in atrial fibrillation after coronary artery bypass surgery; a double-blind randomized controlled clinical trial","volume":"6","author":"Esmail","year":"2015","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0002-9149(99)00698-0","article-title":"Amiodarone: Ionic and cellular mechanisms of action of the most promising class III agent","volume":"84","author":"Kodama","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(97)00114-4","article-title":"Cellular electropharmacology of amiodarone","volume":"35","author":"Kodama","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yoon, J.-H., Jeon, C.-W., and Kim, J.-E. (2026). Transitioning Amiodarone Tablet Manufacturing: A Comparative Study of Batch and Continuous Wet Granulation. Pharmaceuticals, 19.","DOI":"10.3390\/ph19060850"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Essebag, V. (1995). Class I and class III antiarrhythmic agents: Mechanisms of action and the problem of proarrhythmic activity. McGill J. Med., 1.","DOI":"10.26443\/mjm.v1i2.723"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"176127","DOI":"10.1016\/j.ejphar.2023.176127","article-title":"Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Nav1. 5 depends on the extracellular pH","volume":"960","author":"Marques","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"116513","DOI":"10.1016\/j.biopha.2024.116513","article-title":"The ion channel basis of pharmacological effects of amiodarone on myocardial electrophysiological properties, a comprehensive review","volume":"174","author":"Gelman","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104521","DOI":"10.1016\/j.phrs.2019.104521","article-title":"The role of amiodarone in contemporary management of complex cardiac arrhythmias","volume":"151","author":"Dobrev","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jeon, C.-W., Yoon, J.-H., and Kim, J.-E. (2026). Comparative evaluation and improvement of the analytical method for amiodarone hydrochloride: Replacing the pharmacopeial method with a validated RP-HPLC technique. Appl. Sci., 16.","DOI":"10.3390\/app16041920"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115071","DOI":"10.1016\/j.jpba.2022.115071","article-title":"Emerging analytical techniques for pharmaceutical quality control: Where are we in 2022?","volume":"221","author":"Dispas","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_12","first-page":"1000105","article-title":"Validation of an HPLC-UV method for the determination of amiodarone impurities in tablet formulations","volume":"1","year":"2010","journal-title":"Pharm. Anal. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.chroma.2009.01.036","article-title":"A new approach to the determination of column overload characteristics in reversed-phase liquid chromatography","volume":"1216","author":"Dai","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1021\/ac0202381","article-title":"Overloading study of bases using polymeric RP-HPLC columns as an aid to rationalization of overloading on silica-ODS phases","volume":"74","author":"Buckenmaier","year":"2002","journal-title":"Anal. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"010","DOI":"10.29328\/journal.aac.1001026","article-title":"High-Performance Liquid Chromatography (HPLC): A review","volume":"6","author":"Hussen","year":"2022","journal-title":"Ann. Adv. Chem."},{"key":"ref_16","first-page":"1190","article-title":"Validation of Analytical Methods in a Pharmaceutical Quality System: An Overview Focused on HPLC Methods","volume":"43","author":"Marson","year":"2020","journal-title":"Qu\u00edm. Nova"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s43094-021-00286-4","article-title":"QbD approach to HPLC method development and validation of ceftriaxone sodium","volume":"7","author":"Patel","year":"2021","journal-title":"Future J. Pharm. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jeon, C.-W., Yoon, J.-H., and Kim, J.-E. (2026). QbD-Based Formulation Development of Amiodarone Hydrochloride Tablet. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18020264"},{"key":"ref_19","first-page":"05","article-title":"Validation of analytical procedures: Text and methodology","volume":"1","author":"Guideline","year":"2005","journal-title":"Q2 (R1)"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.jcoa.2022.100052","article-title":"Analytical quality by design assisted RP-HPLC method for quantifying atorvastatin with green analytical chemistry perspective","volume":"2","author":"Kokilambigai","year":"2022","journal-title":"J. Chromatogr. Open"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kim, D.-H., Lee, S.-E., and Kim, J.-E. (2026). Development and Validation of RP-HPLC Method for Simultaneous Assay and Dissolution Quantitative Analysis of Pitavastatin-Fenofibrate Complex Dual-Layered Tablets. Appl. Sci., 16.","DOI":"10.3390\/app16062962"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yoon, J.-H., Kim, D.-H., and Kim, J.-E. (2026). Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18040440"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Damjanoska, A., Mitreska, K., Petrova, M., Acevska, J., Brezovska, K., and Nakov, N. (2025). Dimethyl Isosorbide: An Innovative Bio-Renewable Solvent for Sustainable Chromatographic Applications. Molecules, 30.","DOI":"10.3390\/molecules30132713"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"113659","DOI":"10.1016\/j.microc.2025.113659","article-title":"Strategies for the development and optimization of green acetonitrile-free HPLC methods for application in pharmaceutical analysis","volume":"213","author":"Neto","year":"2025","journal-title":"Microchem. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99269-x","article-title":"Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product","volume":"12","author":"Kowalska","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"122512","DOI":"10.1016\/j.jchromb.2020.122512","article-title":"Validation of a HPLC-UV method for the quantification of budesonide in skin layers","volume":"1164","author":"Demurtas","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"ref_27","first-page":"1","article-title":"Selection of Analytical Technology and Development of Analytical Procedures Using the Analytical Target Profile","volume":"94","author":"Borman","year":"2021","journal-title":"Anal. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/sscp.70043","article-title":"Application of Box\u2013Behnken Design and Green Analytical Chemistry Principles in Development of HPLC Method to Simultaneously Analyze Combination of Chlorthalidone, Bisoprolol Fumarate, and Cilnidipine","volume":"8","author":"Chadha","year":"2025","journal-title":"Sep. Sci. Plus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982104.2023.2208662","article-title":"Development and characterization of novel surface engineered Depofoam: A QbD coupled failure modes and effects analysis risk assessment-based optimization studies","volume":"34","author":"Koilpillai","year":"2024","journal-title":"J. Liposome Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"117206","DOI":"10.1016\/j.jpba.2025.117206","article-title":"Strategic method development for praziquantel impurity analysis using analytical QbD framework","volume":"268","author":"Mastoras","year":"2026","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1255\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:24:20Z","timestamp":1786325060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ph19081255"],"URL":"https:\/\/doi.org\/10.3390\/ph19081255","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}